For the quarter ending 2025-12-31, MOBX had -$3,005K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Issuance of warrants to placement agent | - | - | 280 |
| Change in fair value of pipe make-whole liability | - | 0 | 0 |
| Merger-related transaction costs expensed | - | 0 | 0 |
| Impairment of long-lived assets | - | 0 | 725 |
| Net loss and comprehensive loss | -10,125 | -15,729 | -30,402 |
| Depreciation | 49 | 60 | 306 |
| Issuance of warrants in connection with financing activities, charged to expense | - | 6,458 | 0 |
| Amortization of intangible assets | 406 | 407 | 1,285 |
| Loss on disposal of assets | - | - | -472 |
| Change in fair value of earnout liability | 960 | -50 | 490 |
| Change in fair value of warrants | 323 | 433 | -1,237 |
| Non-cash expense for warrants issued | 514 | - | - |
| Stock-based compensation | 5,139 | 5,363 | 20,256 |
| Private placement costs expensed | - | 280 | - |
| Deferred income taxes | -28 | 16 | -15 |
| Other non-cash items | -551 | -516 | -235 |
| Accounts receivable | -271 | -99 | -1,331 |
| Inventory | -266 | 189 | -479 |
| Prepaid expenses and other assets | -180 | -115 | 104 |
| Accounts payable | -807 | -1,659 | 376 |
| Proceeds from issuance of notes payable-Related Party | - | 0 | - |
| Accrued expenses and other current liabilities | -544 | 19 | 903 |
| Proceeds from issuance of convertible notes | - | - | 0 |
| Proceeds from the merger and pipe | - | 0 | 0 |
| Net cash used in operating activities | -4,765 | -4,513 | -5,600 |
| Merger-related transaction costs paid | - | 0 | 0 |
| Acquisitions of businesses, net of cash acquired | - | -16 | 16 |
| Proceeds from sale of common stock and warrants in private placements | - | 3,645 | - |
| Proceeds from sale of property and equipment | - | 0 | 27 |
| Proceeds from issuance of common stock | 1,254 | 1,000 | 600 |
| Acquisition of property and equipment | - | 26 | 0 |
| Proceeds from exercise of common stock warrants | - | 4,503 | 17 |
| Net cash provided by (used in) investing activities | - | -10 | 11 |
| Proceeds from exercise of stock options | 55 | 0 | 0 |
| Proceeds from sale of common stock and warrants in private placement | - | - | 3,645 |
| Principal payments on notes payable related parties | - | 129 | 445 |
| Proceeds from issuance of notes payable-Nonrelated Party | - | 5,317 | - |
| Proceeds from issuance of notes payable | -858 | - | 2,575 |
| Deferred consideration paid for acquisitions of businesses | - | 0 | -174 |
| Principal payments on notes payable | 1,266 | 560 | 655 |
| Net cash provided by financing activities | 1,760 | 7,556 | 5,563 |
| Net increase (decrease) in cash | -3,005 | 3,033 | -26 |
| Cash and cash equivalents at beginning of period | 3,273 | 266 | - |
| Cash and cash equivalents at end of period | 268 | 3,273 | - |
MOBIX LABS, INC (MOBX)
MOBIX LABS, INC (MOBX)